Steris

NYSE: STE

Stock price

217.84 USD

(+Infinity%) NaN day

Financial Performance

Share

5Y price score: 6

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 239%

DATE RANGE:

US$ Per
Share

By default your notes are visible only to you.

195.1

52-week range

269.4

217.84

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

4.5 %

Dividend Yield TTM

1.2 %

Market cap $

$ 21,230

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

27.5

Price / Book TTM

3

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

1

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

(2) %

9.4 %

239 %

Free cash flow per share growth

25.5 %

87.9 %

446.8 %

Earnings per share growth

27.9 %

71.3 %

408.3 %

Founded: 1,985

Employees: 18,000

Business Summary:STERIS plc operates as a global provider, delivering a wide array of products and services crucial for infection prevention and various procedural needs. The company's operations are strategically divided into four primary segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare division offers a comprehensive suite of solutions, encompassing specialized cleaning chemicals and sterility assurance products. It also provides automated systems for endoscope reprocessing and tracking, alongside critical capital equipment for sterile processing departments, such as washers, sterilizers, and accessories for gastrointestinal (GI) procedures. Additionally, this segment furnishes essential operating room equipment, including surgical tables, lighting, and connectivity solutions. Beyond products, the Healthcare division offers extensive support services, which include equipment management, installation, maintenance, upgrades, repairs, and troubleshooting for capital assets. It also delivers preventive maintenance programs, general repair services, and specialized instrument and endoscope repair. Furthermore, the division provides tailored consulting for process improvement and manages outsourced sterile processing services for instruments. The Applied Sterilization Technologies segment specializes in offering outsourced sterilization and testing services. These are provided to manufacturers of medical devices and pharmaceuticals through its expansive network of approximately 50 dedicated contract sterilization and laboratory facilities. In the Life Sciences sector, STERIS focuses on the design, production, and sale of consumable items. These include formulated cleaning chemistries, barrier and sterility assurance products, various sterilizers (both steam and vaporized hydrogen peroxide), and washer disinfectors. This segment also provides equipment installation, maintenance, upgrades, repairs, and troubleshooting, in addition to preventive maintenance programs. Finally, the Dental segment caters to dental practices by supplying a range of hand and powered dental instruments, infection control solutions, personal protective equipment (PPE), and products designed to maintain water quality within dental suites. STERIS's diverse portfolio of products and services reaches a broad clientele, including hospitals, other healthcare institutions, and pharmaceutical manufacturers. Established in 1985, STERIS plc maintains its corporate headquarters in Dublin, Ireland.

Fair Value Reference Estimate

Latest Earnings Call Takeaways

Annual Reports, Presentations And IR Contacts

Go to the website

Steris — Financial Overview, Stock Price, Market Cap

Steris is a company. Founded in 1985. As of July 20, 2026, the company's market capitalization is $21230185368 with a current stock price of $217.84.